Short QT interval: A novel predictor of androgen abuse in strength trained athletes

Annals of Noninvasive Electrocardiology

Volumn 14, Issue 1, 2009, Pages 35-39

  Bigi, Mohammad Ali Babaee ^a   Aslani, Amir ^a,b   Aslani, Arsalan ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anabolic steroid; Bodybuilding; QT interval

Indexed keywords

ANABOLIC AGENT; ANDROGEN;

ADULT; AGE DETERMINATION; ARTICLE; ATHLETE; CLINICAL EXAMINATION; CONTROL GROUP; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; INDEPENDENT VARIABLE; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; QT INTERVAL; SEX DETERMINATION; SHORT QT INTERVAL; TRAINING;

ADULT; ANABOLIC AGENTS; ANDROGENS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DOPING IN SPORTS; ELECTROCARDIOGRAPHY; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROBABILITY; RESISTANCE TRAINING; ROC CURVE; SENSITIVITY AND SPECIFICITY; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 58449108288     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00271.x     Document Type: Article

References (15)

1. Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004 34 : 513 554.
2. Sullivan ML, Martinez CM, Gennis P, et al. The cardiac toxicity of anabolic steroids. Prog Cardiovasc Dis 1998 41 : 1 15.
3. Kutscher EC, Lund BC, Perry PJ. Anabolic steroids a review for the clinician. Sports Med 2002 32 : 285 296.
4. Stolt A, Karila T, Viitasalo M, et al. QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids. Am J Cardiol 1999 84 : 364 366.
5. Schanzer W. Abuse of androgens and detection of illegal use. In : Nieschlag E, Behre HM (eds Testosterone: Action, Deficiency, Substitution, Heidelberg, Springer, 1998, pp. 545 566.
6. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements. Circulation 1978 58 : 1072 1083.
7. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977 55 : 613 618.
8. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986 57 : 450 458.
9. Nottin S, Nguyen LD, Terbah M, et al. Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging. Am J Cardiol 2006 97 : 912 915.
10. Buckley W, Yesalis C, Friedl K, et al. Estimated prevalence of anabolic steroid use among male high-school seniors. JAMA 1988 260 : 3441 3445.
11. Melchert RB, Welder AA. Cardiovascular effects of androgenic anabolic steroids. Med Sci Sports Exerc 1995 27 : 1252 1262.
12. Ferenchick GS, Adelman S. Myocardial infarction associated with anabolic steroid use in a previously healthy 37-year old weightlifter. Am Heart J 1992 124 : 507 508.
13. IOC. Medical Code. Lausanne, Switzerland, International Olympic Committee, 1995, ISBN 92-9149-003-2.
14. Fülöp L, Bányász T, Szabó G, et al. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol (Oxf) 2006 188 : 163 171.
15. Liu XK, Katchman A, Whitfield BH, et al. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res 2003 57 : 28 36.